These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33839043)

  • 1. Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.
    Davis J; Boughey JC; Hoskin TL; Day CN; Cheville JC; Piltin MA; Hieken TJ
    Clin Breast Cancer; 2021 Oct; 21(5):458-465. PubMed ID: 33839043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Stafford AP; Hoskin TL; Day CN; Sanders SB; Boughey JC
    Ann Surg Oncol; 2022 Aug; 29(8):4740-4749. PubMed ID: 35451727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study.
    Hennigs A; Riedel F; Feißt M; Köpke M; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Heil J
    Ann Surg Oncol; 2019 Aug; 26(8):2435-2443. PubMed ID: 31049766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy.
    Williams AD; Khan AJ; Sevilimedu V; Barrio AV; Morrow M; Mamtani A
    Ann Surg Oncol; 2022 Dec; 29(13):8037-8043. PubMed ID: 35951137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intraoperative assessment of sentinel nodes - Standards and controversies.
    van der Noordaa MEM; Vrancken Peeters MTFD; Rutgers EJT
    Breast; 2017 Aug; 34 Suppl 1():S64-S69. PubMed ID: 28673534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes.
    Kantor O; Means J; Grossmith S; Dey T; Bellon JR; Mittendorf EA; King TA
    Ann Surg Oncol; 2022 Feb; 29(2):972-980. PubMed ID: 34467507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.
    Espinosa-Bravo M; Navarro-Cecilia J; Ramos Boyero M; Diaz-Botero S; Dueñas Rodríguez B; Luque López C; Ramos Grande T; Ruano Perez R; Peg V; Rubio IT
    Breast; 2017 Feb; 31():40-45. PubMed ID: 27810698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer.
    Sanders SB; Hoskin TL; Stafford AP; Boughey JC
    Ann Surg Oncol; 2022 Nov; 29(12):7769-7778. PubMed ID: 35834142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of intraoperative frozen section diagnosis of sentinel lymph nodes in breast cancer.
    Wada N; Imoto S; Hasebe T; Ochiai A; Ebihara S; Moriyama N
    Jpn J Clin Oncol; 2004 Mar; 34(3):113-7. PubMed ID: 15078905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
    Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
    Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of frozen section in sentinel lymph node biopsy for breast cancer in the era of the ACOSOG Z0011 and IBCSG 23-10 trials.
    Lombardi A; Nigri G; Maggi S; Stanzani G; Vitale V; Vecchione A; Nania A; Amanti C
    Surgeon; 2018 Aug; 16(4):232-236. PubMed ID: 29329752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative axillary ultrasound in breast cancer: safely avoiding frozen section of sentinel lymph nodes in breast-conserving surgery.
    Ibrahim-Zada I; Grant CS; Glazebrook KN; Boughey JC
    J Am Coll Surg; 2013 Jul; 217(1):7-15; discussion 15-6. PubMed ID: 23628226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
    Hennigs A; Köpke M; Feißt M; Riedel F; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Schneeweiss A; Heil J
    Breast Cancer Res Treat; 2019 Jan; 173(2):429-438. PubMed ID: 30315437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordance of intraoperative frozen section analysis with definitive histology of sentinel lymph nodes in breast cancer surgery: complementary axillary lymph node dissection is irrelevant for subsequent systemic therapy.
    Geertsema D; Gobardhan PD; Madsen EV; Albregts M; van Gorp J; de Hooge P; van Dalen T
    Ann Surg Oncol; 2010 Oct; 17(10):2690-5. PubMed ID: 20422461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node metastasis in patients with frozen section analyses that are negative for tumors.
    Lee SK; Lee KW; Kim S; Choi MY; Kim J; Lee J; Jung SP; Choe JH; Kim JH; Kim JS; Lee JE; Yang JH; Nam SJ
    Oncology; 2012; 83(1):31-7. PubMed ID: 22722529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy.
    Tadros AB; Moo TA; Stempel M; Zabor EC; Khan AJ; Morrow M
    Breast Cancer Res Treat; 2020 Feb; 180(1):197-205. PubMed ID: 31938938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing non-sentinel axillary metastases in patients with T3-T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy.
    Riedel F; Heil J; Feisst M; Moderow M; von Au A; Domschke C; Michel L; Schaefgen B; Golatta M; Hennigs A
    Breast Cancer Res Treat; 2020 Nov; 184(2):627-636. PubMed ID: 32816190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?
    Moo TA; Edelweiss M; Hajiyeva S; Stempel M; Raiss M; Zabor EC; Barrio A; Morrow M
    Ann Surg Oncol; 2018 Jun; 25(6):1488-1494. PubMed ID: 29572705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating Lymphovenous Anastomosis in Clinically Node-Positive Women Receiving Neoadjuvant Chemotherapy: A Shared Decision-Making Model and Nuanced Approached to the Axilla.
    Lustig DB; Temple-Oberle C; Bouchard-Fortier A; Quan ML
    Curr Oncol; 2023 Apr; 30(4):4041-4051. PubMed ID: 37185419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.